Treatment as a single agent in MCF-7 xenograft, combination with taxanes or gefitinib in KPL-4 orthotopic mouse model, and trastuzumab-resistant breast tumor xenograft mouse model (BT474-PTEN-LTT). This evidence concerns the gene PTEN and breast neoplasm.